Physician
Arizona Pain and Spine Institute PLLC
Arizona Pain and Spine Institute PLLC was paid $3.85M by Medicaid between Jan 2018 and Dec 2024, across 38 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 36% of everything it billed.
33Billing provider infoARIZONA PAIN AND SPINE INSTITUTE PLLC
MESA, AZ 85210
MESA, AZ 85210
33aNPI1316147242assigned 07/19/2007
33bProvider typePain Medicine (Physical Medicine & Rehabilitation) Physician
28Total paid$3.85M
24GClaims89,690
24DCodes billed38
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pain Medicine (Physical Medicine & Rehabilitation) Physician providers in Arizona
Rank by total paid#1 of 12
Median peer was paid$97K
This provider vs. median40×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 21,155 | $887K | |
| 2019 | 18,323 | $741K | |
| 2020 | 16,308 | $692K | |
| 2021 | 12,781 | $551K | |
| 2022 | 9,335 | $430K | |
| 2023 | 6,871 | $321K | |
| 2024incomplete | 4,917 | $227K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 36% | 28,130 | 26,423 | $1.39M |
| 64483 | 17% | 3,547 | 2,668 | $673K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 9.7% | 11,092 | 10,560 | $374K |
| 64635 | 7.1% | 1,249 | 802 | $274K | |
| 64636 | 5.7% | 1,231 | 783 | $219K | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | 5.3% | 1,587 | 1,523 | $205K |
| 99152 | 4.2% | 6,717 | 4,646 | $160K | |
| 20611 | 4.0% | 2,573 | 1,869 | $155K | |
| 20553 | 2.0% | 1,771 | 1,608 | $76K | |
| 76942 | 1.7% | 1,923 | 1,719 | $65K | |
| 62321 | 1.3% | 304 | 231 | $50K | |
| 64493 | 1.2% | 362 | 282 | $46K |
26 more codes
| 99215 | Doctor's office visit, returning patient (complex) | 1.0% | 568 | $40K |
| 64495 | <1% | 325 | $21K | |
| 64494 | <1% | 324 | $20K | |
| J1020 | Injection, methylprednisolone acetate, 20 mg | <1% | 7,120 | $19K |
| 64484 | <1% | 223 | $13K | |
| 95910 | <1% | 101 | $11K | |
| J7323 | Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | <1% | 112 | $10K |
| 76881 | <1% | 148 | $8K | |
| 80305 | <1% | 4,396 | $8K | |
| 95886 | <1% | 72 | $5K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 7,547 | $2K |
| 81025 | <1% | 238 | $1K | |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | <1% | 1,617 | $1K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 568 | $1K |
| A4221 | Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately) | <1% | 83 | $627.17 |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 12 | $447.55 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 560 | $261.16 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 52 | $211.71 |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 25 | $190.31 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 15 | $186.78 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 113 | $81.21 |
| A4306 | Disposable drug delivery system, flow rate of less than 50 ml per hour | <1% | 876 | $20.90 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 3,851 | $20.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 13 | $19.69 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | <1% | 221 | $9.52 |
| A4215 | Needle, sterile, any size, each | <1% | 24 | $0.06 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKHAN, ASIM (MEMBER)